These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

603 related items for PubMed ID: 17532532

  • 1. Emerging trends in the therapy of COPD: bronchodilators as mono- and combination therapies.
    Fitzgerald MF, Fox JC.
    Drug Discov Today; 2007 Jun; 12(11-12):472-8. PubMed ID: 17532532
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Bronchodilators in chronic obstructive pulmonary disease (COPD)].
    Gillissen A, Buhl R, Rabe KF, Vogelmeier C, Welte T.
    Med Klin (Munich); 2005 May 13; 100(5):246-54. PubMed ID: 15902378
    [Abstract] [Full Text] [Related]

  • 4. The future of combining inhaled drugs for COPD.
    Bjerg A, Lundbäck B, Lötvall J.
    Curr Opin Pharmacol; 2012 Jun 13; 12(3):252-5. PubMed ID: 22465638
    [Abstract] [Full Text] [Related]

  • 5. Bronchodilators: current and future.
    Cazzola M, Matera MG.
    Clin Chest Med; 2014 Mar 13; 35(1):191-201. PubMed ID: 24507846
    [Abstract] [Full Text] [Related]

  • 6. Roflumilast for the treatment of chronic obstructive pulmonary disease.
    Antoniu SA.
    Curr Opin Investig Drugs; 2006 May 13; 7(5):412-7. PubMed ID: 16729716
    [Abstract] [Full Text] [Related]

  • 7. Pharmacology and therapeutics of bronchodilators.
    Cazzola M, Page CP, Calzetta L, Matera MG.
    Pharmacol Rev; 2012 Jul 13; 64(3):450-504. PubMed ID: 22611179
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Emerging trends in the therapy of COPD: novel anti-inflammatory agents in clinical development.
    Fitzgerald MF, Fox JC.
    Drug Discov Today; 2007 Jun 13; 12(11-12):479-86. PubMed ID: 17532533
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacologic therapy for acute exacerbations of chronic obstructive pulmonary disease: a review.
    Hockman RH.
    Crit Care Nurs Clin North Am; 2004 Sep 13; 16(3):293-310, vii. PubMed ID: 15358379
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA.
    Clin Ther; 2007 Oct 13; 29(10):2121-33. PubMed ID: 18042470
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [How risky are beta-2 mimetics?].
    Paukstadt W.
    MMW Fortschr Med; 2006 Aug 17; 148(33-34):10. PubMed ID: 16981376
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [New drug therapy of chronic obstructive pulmonary disease].
    Kino H.
    Nihon Rinsho; 2003 Dec 17; 61(12):2175-80. PubMed ID: 14674329
    [Abstract] [Full Text] [Related]

  • 19. Chronic obstructive pulmonary disease.
    Kerstjens H, Postma D, ten Hacken N.
    Clin Evid; 2006 Jun 17; (15):2077-100. PubMed ID: 16973079
    [No Abstract] [Full Text] [Related]

  • 20. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma.
    Buhl R, Farmer SG.
    Proc Am Thorac Soc; 2004 Jun 17; 1(2):136-42. PubMed ID: 16113426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.